close
close

WHO erklärt Mpox-Ausbruch zur internationalen Bedrohung – Euractiv DE

WHO erklärt Mpox-Ausbruch zur internationalen Bedrohung – Euractiv DE

The Notfallausschuss der Weltgesundheitsorganisation (WHO) kam am Mittwoch (August 14) in Geneva. It may be that the youngest Ausbruch of Mpox has become an international Gesundheitsnotstand (GNIT).

WHO General Dr Tedros Adhanom Ghebreyesus has notarized a new variant of the invading Mpox virus in the Democratic Republic of Congo (DRC) and in the states of Burundi, Rwanda, Kenya and Uganda.

WHO will beruft Notfallausschuss roads new Affenpocken-Variante ein

The General Director of the World Health Organization (WHO) can arrange the Einberufung eines Notfallausschchusses. This is the only way in which the new Ausbruch von Affenpocken (Mpox) darstellt a healthy international Notlage Tragweite (GNIT).

“It is clear that there has been an international response, a way to stop and stay,” Tedros said.

The Afrikanische Zentrum für Krankheitskontrolle (Africa CDC) has deployed a Continental Health Care Monitor (PHECS) at the service (13 August).

“It is not an African problem. Mpox is a global Bedrohung, a Bedrohung that knows no Borders, no Ethnicity and no Ideology,” explained Dr. Jean Kaseya, General Director of the African Centers. “There is a virus that harms us and is our evil punk. A genau in those moments of the distorted barkeit will find our great support and say, that all COVID-19 matters will develop, indem with solidarity trade.”

Mpox wurde 2022 zur gesundheitlichen Notlage internationaler Tragweite (GNIT) clear. This Zeitpunkt breitete sich der Erreger über de Democratic Republik Kongo is one of the many states, or in the EU, nachgewiesen. The alert will take place in May 2023.

On August 16, the European Center for Disease Control (ECDC) started an active risk assessment for the states of the EU and the European Economic Area. We will be happy to inform you about the health and safety of the EU during the month of Monday (19 August).

Imperfections

The European Authority for the Crisis Response to Health Concerns (HERA) has procured 175,420 doses of MVA-BN® impurities and sent them as instant doses to the African Center for Disease Control. MVA-BN is one of the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) that uses Mpox impurities, and as an unrestricted response to Mpox extraction in Africa could be carried out.

It is important to know that the repairs are carried out by the pharmaceutical manufacturer Bavarian Nordic, HERA 40,000 doses for repairs. The African center offers the opportunity to spread the regional regional markets.

There is now a state where a notification for the impfstoff has been carried out. The WHO has requested Bavarian Scandinavian products, an interest for a list of impfstoffs for the notifications. If you want to buy the African government bonds, while there is not yet a single national government bond, this can be carried out like this.

“Starke Globale Partnerschaften since der Kern unserer Europäischen Gesundheitsunion”, erklärte Gesundheitskommissarin Stella Kyriakides. “Health care knows no boundaries and thanks to the Zusammenarbeit zwischen der Europäische Kommission, the African Center for Health Control and Bavarian Nordic institutions with a value of 215,000 Impfstoffe zur Verfügung, one of the strong affected people in the form of Mpox-Ausbruch in Africa affected Ländern zu schüt zen .“

Kyriakides said that there was a profound reaction and boundless solidarity action when “Care and response to general development are a global challenge.”